We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 258

News Bytes - May 16, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The National Institutes of Health (NIH) Office of Biotechnology Activities proposes revising the "NIH Guidelines for Research Involving Recombinant

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Biotech receives $32.5 million for cancer research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Celator Pharmaceuticals, Inc., a Princeton, New Jersey-based company that develops cancer therapies, has raised $32.5 million in the final closing of

Congress advances pharma supply chain and animal-drug user-fee laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The House Energy and Commerce Subcommittee on Health has reportedly approved draft legislation that would change the existing lot-level

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Biopharmaceuticals to collaborate on cancer drug discovery

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

FORMA Therapeutics Holdings, LLC has reportedly entered a strategic collaboration agreement with Celgene Corp. to discover, develop and commercialize

House appropriators concerned about sequestration of FDA user fees

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Food and Drug Administration (FDA) Commissioner Margaret Hamburg reportedly testified before a House Appropriations Subcommittee about the effects of

News Bytes - May 2, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

The National Nanotechnology Coordination Office schedules a June 11-12, 2013, public workshop in Washington, D.C., "to obtain input from stakeholders

U.S. Senators propose subjecting compounded drugs to federal regulation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 2 2013

Bipartisan Senate health committee leaders have released draft legislation that would give the Food and Drug Administration (FDA) greater oversight

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy